Navigation Links
WuXi PharmaTech Receives GLP Certificate from SFDA for Suzhou Toxicology Facility
Date:8/16/2012

the Suzhou toxicology facility.

"WuXi's receipt of this certificate is further acknowledgment that we offer our clients non-clinical laboratory studies that meet national and international GLP quality standards," said Edward Hu, Chief Operating Officer and Chief Financial Officer of WuXi PharmaTech.  "This award is additional confirmation of WuXi capability in offering our pharmaceutical and biotech clients a comprehensive, fully integrated platform of pharmaceutical R&D services."

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States.  As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process.  WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D.  WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec.  For more information, please visit http://www.wuxiapptec.com or contact:

Aaron Shi (for the media)
Tel:   +86-21-5046-4362
Email: Aaron_Shi@wuxiapptec.com

Ronald Aldridge (for investors)
Tel:   +1-201-585-2048
Email: Ron_Aldridge@wuxiapptec.com


'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. WuXi PharmaTech Announces Second-Quarter 2012 Results
2. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
3. WuXi PharmaTech Announces First-Quarter 2012 Results
4. Industry Leading Pharmaceutical News Website in-Pharmatechnologist.com Refocused and Relaunched
5. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
6. Perrigo Receives FDA Approval And Commences Launch Of Clobetasol Propionate Shampoo, 0.05%
7. GeNO LLC Receives FDA Marketing Clearance For Its Inhaled Nitric Oxide Drug Delivery Device
8. First Warning Systems Receives Investment by Members of the Reno Angels and Local Investors
9. iMD Companies Inc. receives shares of Positive Solutions
10. Genelex Receives First Patent on Business Methods for Pharmacogenetics
11. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 Dr. Davis Lee ... of four recipients of the 2013 AMDIS Award, a ... medical informatics. "On behalf of Allscripts, ... in leadership, innovation and continuous efforts to improve patient ... , President and Chief Executive Officer of Allscripts. "We ...
(Date:6/19/2013)... INDIANAPOLIS , June 19, 2013 Eli ... issued an alert about two illegal scams, purportedly using ... Animal Health, that are actively targeting the public through ... and Elanco have no connection to any foreign lottery ... recruiting described by the job-seeking victims of the scam. ...
(Date:6/19/2013)... 2013 Pharmacyclics, Inc. (the "Company") (Nasdaq: ... England Journal of Medicine ( NEJM ) published ... investigational oral Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib in ... lymphocytic lymphoma (SLL). Ibrutinib was shown to be safe ... even in patients who were at high-risk due to ...
Breaking Medicine Technology:Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 2Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 3Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 4Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 5Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6
... 27, 2011 Express Scripts, Inc. (Nasdaq: ESRX ... conferences in November: Credit Suisse 2011 Healthcare Conference ... a.m. eastern). Lazard Capital Markets, 8th Annual Healthcare ... These presentations will also be broadcast via ...
... WARWICK, R.I., Oct. 27, 2011 ... the power of connected healthcare in partnership with ... Virtual Lifetime Electronic Records (VLER) initiative for veterans ... electronic medical records for veterans and military personnel ...
Cached Medicine Technology:MEDfx Demonstrates Potential of Connected Healthcare by Enabling Military and Civilian Medical Professionals to Securely Access Records, Improve Care Coordination 2
(Date:6/20/2013)... AZ (PRWEB) June 20, 2013 Pedata ... recreational vehicle sales, warns campers that improperly handled food can ... , Now that summertime has arrived, many RV campers are ... fresco. Whether they are eating outdoors at the campground or ... are ever present and should be avoided at all costs. ...
(Date:6/20/2013)... 2013 TASC, a national leader ... new service to deal with funding the Patient-Centered ... Protection & Affordable Care Act (PPACA), the PCORI ... clinical effectiveness, and appropriateness" of different medical treatments. ... its own, with funding in part by employer-paid ...
(Date:6/20/2013)... June 20, 2013 Startups who need ... their sales or test new markets, and international companies ... have a new sales outsourcing company to ... revenue. , Strategy Sales Partners is a ... by business owners for business owners, Strategy Sales Partners ...
(Date:6/19/2013)... Everyone is looking for ways to improve general health. Sublime Beauty® ... is called Skin Brushing . Skin Brushing can be incorporated ... to improve health and skin quality. It is fun to ... Brushing improves general health because:, , it boosts ... drain toxins , it clears skins of dead cells ...
(Date:6/19/2013)... 2013 Go Classy Tours has the reputation ... for over 25 Years. These resorts, draw many clients ... nude bars and nude hot tubs. Grand Lido Negril ... When SuperClubs re-branded the resort to a Breezes and dis-continued ... of the Resort fell off dramatically. "Groups just went ...
Breaking Medicine News(10 mins):Health News:Pedata RV Center Warns Campers of the Dangers of Mishandled Food 2Health News:Pedata RV Center Warns Campers of the Dangers of Mishandled Food 3Health News:TASC Service Helps Employers Handle New Burdens for Health Reimbursement Arrangement Plans 2Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 2Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 3Health News:A Fast and Fun Way to Better Skin Quality and Overall Health, says Sublime Beauty® 2Health News:The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours 2
... MD The American Institute of Ultrasound in ... Point-of-Care Use of Ultrasound on November 8 ... a cross section of the ultrasound community, drawing ... to explore professional issues related to emerging point-of-care ...
... The presence of one to four circulating tumor cells ... doubled patient,s risk of cancer relapse and death, and five ... by 300 percent, according to Phase III results of the ... but before chemotherapy treatment. Results of this study were ...
... cancer patients who had circulating tumor cells (CTCs) in ... by autologous stem cell transplantation had poor outcomes, according ... Cancer Center. Patients with CTCs in their ... with these cells in their blood after the stem ...
... resistance, a triple-drug cocktail for triple negative breast cancer, ... study highlights scheduled to be presented by Johns Hopkins ... San Antonio Breast Cancer Symposium, held Dec. 8-12. ... at the symposium. SIMPLE FINGERTIP TEST MAY IDENTIFY ...
... -- Toddlers who play with different-shaped objects learn new words ... have similar shapes, a new study finds. University of ... old and knew about 17 object names at the start ... objects by playing with toys that were nearly identical, while ...
... By Maureen Salamon HealthDay Reporter , FRIDAY, ... considered nature,s ideal nourishment for babies. But some ... subject of fresh scrutiny by the U.S. Food and Drug ... share their milk with needy infants at all. ...
Cached Medicine News:Health News:AIUM spearheads collaboration to develop guidelines for point-of-care ultrasound applications 2Health News:Circulating tumor cells predicted recurrence, death in patients with early-stage breast cancer 2Health News:CTCs predict poor outcome from blood stem cell transplantation therapy for metastatic breast cancer 2Health News:Simple fingertip test may identify breast cancer patients at risk for carpal tunnel syndrome 2Health News:FDA Weighs In as Sharing of Breast Milk Booms 2Health News:FDA Weighs In as Sharing of Breast Milk Booms 3
Power Supply E865 is ideal for electrophoresis and semi-dry blotting applications. The electrical leads from Hoefer Gel apparatus are fully compatible with this new E865 power supply and there is no ...
... . The digital 200 V/2000 mA PSE ... in 1 volt and 10 mA increments. • ... SEA 2000® apparatus simultaneously at 55°C. Features: ... of voltage, current and time • Voltage, mA ...
... The PowerPac HV high-voltage power ... supports an increased output of ... 400 W. Built-in infrared capability ... Power cord and instructions are ...
... Ultrapure MB Grade PRODUCT SPECIFICATIONS Form: Granular, free-flowing ... to 0.05 Gel Point (3%): less than or equal ... to 75C Gel Strength (3%): greater than or equal ... equal to 10% Sulfate: less than or equal to ...
Medicine Products: